SCHEMBL18200711

SCHEMBL18200711

c1ccc(-c2cc(-c3ccccc3)nc(-c3cnc(-c4nc5ccccc5c5c4ccc4ccccc45)nc3)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.45
HPGD P15428 3/20 0.45
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 2/20 0.45
SMN1; SMN2 Q16637 4/20 0.43
LMNA P02545 3/20 0.43
NPC1 O15118 1/20 0.43
RECQL P46063 1/20 0.43
RAB9A P51151 1/20 0.43
ACHE P22303 1/20 0.39
PTGES O14684 1/20 0.38
NQO2 P16083 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
NTSR1 P30989 1/20 0.37
DHODH Q02127 1/20 0.37
PDE10A Q9Y233 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18200670 0.96 MAPT (0.46) MAPTHPGDKDM4EALDH1A1SMN1; SMN2
SCHEMBL18201268 0.94 MAPT (0.44) MAPTHPGDKDM4EALDH1A1SMN1; SMN2
SCHEMBL18201295 0.94 MAPT (0.44) MAPTHPGDKDM4EALDH1A1SMN1; SMN2
SCHEMBL18201300 0.94 MAPT (0.44) MAPTHPGDKDM4EALDH1A1SMN1; SMN2
SCHEMBL18200678 0.91 NPC1 (0.50) MAPTHPGDKDM4EALDH1A1SMN1; SMN2
SCHEMBL18200710 0.88 NPC1 (0.49) MAPTHPGDKDM4EALDH1A1SMN1; SMN2
SCHEMBL18201061 0.88 MAPT (0.41) MAPTHPGDKDM4EALDH1A1SMN1; SMN2
SCHEMBL18201059 0.86 MAPT (0.41) MAPTHPGDKDM4EALDH1A1SMN1; SMN2
SCHEMBL18201303 0.86 MAPT (0.40) MAPTHPGDKDM4EALDH1A1SMN1; SMN2
SCHEMBL18201254 0.85 MAPT (0.42) MAPTHPGDKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 MAPT 1937/4885HPGD 421/4885KDM4E 1977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.